Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about innovations in gastroenterology technology.
While there aren't many widely-used digital therapeutics in gastroenterology yet, there are many other tehnologies like virtual reality that are growing more and more popular in the field, said Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology.
Transcript
How are digital therapeutics being used in gastroenterology?
I think gastroenterology is not as much exposed to digital therapeutics yet, but there are several upcoming companies that are using various modes. We now know that virtual reality can help with pain, irritable bowel syndrome [IBS], those kinds of things. So, those technologies will probably come up for commercial use in the near future. That's in terms of VR [virtual reality] kind of things.
From a measurement standpoint, right now we have some innovation happening in the IBD [inflammatory bowel disease] space, mostly. Because, if a patient has increased bowels, or we don't know if they're going into a flare, or it's their underlying IBS that's getting worse, you can actually have a kit for fecal calprotectin, which is a measure that we look at when we're looking at inflammation. That kit, you can do it at home. The patient doesn't need to come into the hospital. And you can use your smartphone to know the calprotectin level and that can communicate to your physician's office. You can say, "hey, the [calprotectin level] is high, so I think you are ill. So you need to come into the hospital," or something like that. So there are some technologies out there, but not really directly like a wearable, like Apple Watch, unless you're looking at the role of exercise or some other things for a disease outcome.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More